In a recent virtual meeting, GRI Bio, Inc. (NASDAQ:GRI), a pharmaceutical company whose stock has declined nearly 98% over the past year according to InvestingPro data, received stockholder approval ...

Company committed to building a robust global patent estate across its innovative pipeline of NKT cell modulators LA JOLLA, CA, Dec. 23, 2024 (GLOBE NEWSWIRE) -- GRI Bio, Inc. (NASDAQ: GRI) ...

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (“NKT”) cell modulators for the treatment of ...

GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of Natural Killer T (NKT) cell modulators for the treatment of ...

She currently holds the position of Chief Financial Officer at GRI Bio, Inc., a biotechnology firm focused on developing cell modulators for treating inflammatory, fibrotic, and autoimmune ...

Elevate your confidence by analyzing investor sentiment and stock portfolio shifts, then make your own decisions.

After hours: February 7 at 7:58:28 PM EST ...

After hours: 7:23:12 p.m. EST ...

Mustang Bio (MBIO) announced that it has received notice from Nasdaq informing the company that it has regained compliance with the minimum bid ...